See our roundup of today's AIM risers - see the full LSE winners & losers board here.
Velocys Rises 24% to 4.748p a share
Velocys (VLS) is a company that enables the production of renewable jet fuel and diesel from forestry by-products.
It announced today it was making strong progress with its Bayou Fuels biorefinery project in Mississippi, and discussions are progressing with a shortlist of strategic investors to invest in the project to fund the development costs to financial investment decision. At the end of September, the Company had cash resources in excess of £10 million.
Global demand for the high quality renewable fuels is growing, with increasing demand from airlines and existing jet fuel producers, with British Airways and Shell as partners in its UK waste to jet fuel project.
Read more here & follow VLS here:
Primorus Investments Rises 23% to 0.13p a share
Primorus Investments (PRIM) is an investment company focused on interests in exploration and producing projects and assets in the natural resources sector.
It also has direct and indirect interests the leisure, corporate services, consultancy and brand licensing sectors.
In its interim results for H1 2018 the company reported it had no debt on its balance sheet and total assets of £4.94 million, including £274,000 in cash reserves
Read more here & follow PRIM here:
Active Energy Rises 21% to 2.3p a share
Active Energy (AEG) is an international biomass based renewable energy and forestry management business.
announce that it has entered into a joint venture agreement to install CoalSwitch facilities with Georgia Renewable Power LLC, a US company that maintains three biomass-to-energy power plants located in North Carolina and Georgia.
Michael Rowan, Chief Executive of Active Energy, said “We believe the clear synergies between GRP's business and ours make a compelling proposition and together we look forward to leveraging the benefits of our unique CoalSwitch™ and PeatSwitch™ technologies to develop into new markets.
Read more here & follow AEG here:
Feedback Rises 16% to 1.775p a share
Feedback plc (FDBK) is a specialist medical imaging technology company based in Cambridge, UK.
The company is is seeing considerable sales growth potential in the near to mid-term, especially in Asia, according to a trading update released earlier this month.
It has initiated plans for regulatory approval of TexRAD with the US FDA including 510k as medical device and CFR Chapter 21 part 11 compliance for use in clinical trials of drug candidates for FDA marketing approval
Read more here & follow FDBK here:
See all today's AIM Risers here
